Research article · 27 Sep 2025
PerspectivePublished 22 Jun 2023
An Overview of Arteriovenous Fistula and Graft Failure: Causes, Interventions, and Risks
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Arteriovenous Fistulas (AVFs) and grafts are crucial components in hemodialysis for patients suffering from endstage renal disease. However, their high failure rate remains a considerable challenge in medical practice, often resulting in substantial morbidity and compromised quality of life. This comprehensive review provides an in-depth examination of the potential causes behind AVF and graft failure. This includes, but is not limited to, neointimal hyperplasia, venous hypertension, compromised flow dynamics and infection. It additionally outlines the crucial role of patient demographics and comorbidities. Recognizing the need for efficient and effective intervention in cases of failure, this paper also reviews and compares the techniques and outcomes of balloon angioplasty and mechanical thrombectomy. These procedures are often necessitated by thrombosis and stenosis, significant complications leading to AVF and graft failure. Balloon angioplasty, a standard first-line therapy, is considered for its technical simplicity and relatively low invasiveness. In contrast, mechanical thrombectomy devices, which physically remove thrombi, are typically reserved for balloon angioplasty failure or larger, complex thrombi. Our review then delves into the associated risks and potential complications of these interventions. Notably, rethrombosis and embolization are among the significant risks, which, if not handled promptly and effectively, could lead to more severe complications and poorer patient outcomes. We present the latest statistics and analyze the risk factors contributing to rethrombosis and embolization following balloon angioplasty and mechanical thrombectomy. This review will be beneficial to medical professionals dealing with AVF and graft management, offering a concise, evidence-based examination of failure etiology, therapeutic interventions and their associated risks. We aim to provide a nuanced understanding of these procedures, facilitating informed decision-making in clinical practice and opening avenues for future research to improve patient outcomes and longevity of AVF and grafts.
Keywords
Subjects
Nephrology & UrologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical & Experimental Nephrology.
Research article · 25 Feb 2025
Liver and Kidney Disease and Periodontal Disease: A Cross-sectional Study Based on Data from Oral Health Branch of Rafsanjan Cohort Study
Research article · 31 Jan 2025
HLA-class Ib expression suppresses neutrophil xenogeneic immune responses against pig cells
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical & Experimental Nephrology
- SubjectNephrology & Urology
- BylineArticles whose byline prints “Peter Stibbs”
